Lilly Germany is the first pharmaceutical company to commit itself to the goals of the Economy for the Common Good. Nicole Weichelt and Oliver Stahl have accompanied the process from the beginning. Health Relations, the German publisher of medical publications, has interviewed Nicole Weichelt and Oliver Stahl about the obstacles, competitive advantages and the new corporate culture.
Excerpts from the interview:
“For us, the Common Good Balance Sheet was a logical step, also in order to remain transparent and to resist the temptation to talk things up.”
“In the job market, the Common Good Balance Sheet is a distinct competitive advantage.”
Photo: Nicole Weichelt and Oliver Stahl | Lilly (Retusche)
